Home > Insider Trading > Filing (0001209191-13-026751)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1356857	Trius Therapeutics Inc	TSRX	Pharmaceutical Preparations (2834)	201320630

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1517780	Michael Morneau	C/O Trius Therapeutics, Inc. 6310 Nancy Ridge Dr, # 105 San Diego CA 92121	Vp Finance & Cao	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-05-14	20,000	$4.00	30,635	No	4	M	Direct
Common Stock	Disposition	2013-05-14	20,000	$7.75	10,635	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2013-05-14	20,000	$0.00	20,000	$4.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2020-08-31	No	4	M	Direct

Footnotes

Includes 2,429 shares, 2,249 shares, 1,915 shares, 1,689 shares and 2,353 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on 11/19/10, 5/20/11, 11/18/11, 5/18/12 and 11/20/12, respectively.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2012
25% of the shares subject to the option vested on 1/1/11 with the remainder vesting monthly over 36 months until fully vested on 1/1/14.